The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies.

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

Patients with symptomatic severe aortic stenosis undergoing CoreValve or Evolut TAVI have better 5-year bioprosthetic valve ...

A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...

Auscultation of the heart in patients with aortic stenosis can be very helpful in both the diagnosis and determining the severity of disease. The typical murmur of aortic stenosis is a high ...

DAVID MONTGOMERY: Aortic stenosis is a tightening of one of the four major valves of the heart. The aortic valve is particularly important because the aortic valve is the gateway to the rest of ...

Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.

and potentially surgery An experimental drug originally developed by Sanofi that is now being advanced by the Mayo Clinic significantly curbed progression of aortic valve stenosis, a common heart ...

Experts discuss the clinical and economic burden of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis in the US, exploring their impact on health care systems, the importance of ...

Are you searching for effective medications to treat 'Aortic Valve Stenosis'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential ...

Experts discuss atherosclerotic cardiovascular disease and aortic stenosis, as well as their burden, highlighting their prevalence, impact on patient health, and the growing need for effective ...